Arthritis encompasses around 200 health conditions that affect joints and the tissues in such areas. Osteoarthritis is the most commonly found type of arthritis, and most therapeutics are aimed to combat this condition.

Treatments for arthritis are more prevalent across Europe and North America, which can be attributed to the higher level of patient awareness about the condition in comparison to other places around the world. The global arthritis treamtent market is expected to grow by around 1.5 times through the forecast period till 2027.

The growth can be largely attributed to the growing transition activity from patients from depending on conventional pharmaceuticals to choosing to biologics, as therapy options related to biologics, with the aim of improving patient life substantially. In addition, the industry is witnessing a number of biologics products, which are indicative of superior commercial prospects that are in clinical trials, which are also driving developments in the industry.

Competitive Assessment

The arthritis treatment market report includes global as well as emerging players:

Novartis AG
Eli Lilly and Company
Amgen, Inc.
Merck & Co., Inc.
Bristol-Myers Squibb Company
Pfizer, Inc.
AbbVie, Inc.
Janssen Global Services, LLC (Johnson & Johnson)
Hoffmann-La Roche Ltd
Sanofi

Get the Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=4355

The insights for each vendor consists of:

Company profile
SWOT analysis
Main market information
Market share
Revenue, pricing and gross margin

Europe and North America Dominate Consumption

The arthritis therapeutics market is mostly active around the countries in North America and Europe in comparison to other regions around the globe. This trend can be largely be attributed to the presence of major medical businesses in these region, which are driving a high level of research and development activity in the region.

Such activity helps in boosting the availability of drugs, by strengthening production and development networks and widening product portfolios. Further, the addition of biosimilars and biologics to the list of existing arthritis therapeutics, and the rising number of drugs which are due to face patent enquiries are also expected to aid the growth of the market in the region.

In terms of the Asia Pacific region, an increasing number of investments towards incremental changes in the healthcare industry are expected to contribute to the arthritis therapeutics industry in the region, which will be supported by the continuing adoption of biologics alternatives.

Cost and Recovery Benefits Support Parenteral Administration

In comparison to other modes of administration, oral and topical are expected to be surpassed by parenteral options, owing to tests which have revealed improved patient outcomes through these methods. Parenteral methods have proven to reduce recovery time and treatment costs, and is being supported by the easy availability of biosimilar products, which increased the adoption of injected drugs.

On the other hand, in cases where patients are needed to undergo a longer term of treatment, oral administration of therapeutics is expected to remain the preferred option, while topical administration options are expected to stay strong owing to the introduction of NSAIDs, which have become a popular option to treat joint pain issues.

What insights does the arthritis treatment market report provide to the readers?

Arthritis treatment market fragmentation on the basis of product type, end use, and region.
Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
Collaborations, R&D projects, acquisitions, and product launches of each arthritis treatment market player.
Various regulations imposed by the governments on the consumption of arthritis treatment market in detail.
Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global arthritis treatment market.

For the report methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4355

Questionnaire answered in the arthritis treatment market report include:

What is the present and future outlook of the global arthritis treatment market on the basis of region?
What are the challenges and opportunities for the arthritis treatment market?
Why the consumption of arthritis treatment market highest in region?
In which year segment is expected to overtake segment?